 |
BioWorld-International-2011-07-13
Sunburn Study Pinpoints New Targets for Analgesics
Early Stage Deals Still Wow? Innate Jumps on BMS Alliance
During the recent BIO International Convention in Washington, panelists in a business development session discussed whether biotech firms can count on scoring major dollars by licensing early stage – preclinical or Phase I – programs. (BioWorld International)